KARAWANG, Indonesia -- South Korean biopharmaceutical company SK Plasma's factory in Indonesia is nearing completion, with commercial mass production expected to start in the second half of 2026.

The sun-mimicking technology known as nuclear fusion hopes to create “limitless” energy by smashing light nuclei together using immense heat, but containing such hot plasma is proving tricky. A ...